Nontuberculous mycobacterial (NTM) infections, caused by bacteria from the Mycobacterium genus, are gaining attention in the healthcare and pharmaceutical industries due to their increasing prevalence, particularly among immunocompromised individuals. These infections present significant diagnostic and treatment challenges, highlighting the need for continued research and innovation in...